Antidiabetic Agents in the Management of Hepatic Fibrosis in Type 2 Diabetes Mellitus and MASLD/MASH: A Narrative Review
Hepatic fibrosis is a pathological process resulting from chronic liver injury that represents the primary determinant of disease progression toward cirrhosis and cardiovascular complications. In patients with type 2 diabetes mellitus (T2DM), the risk of hepatic fibrosis is significantly elevated, particularly in the c...